The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA)
The treatment of ACE inhibitors reduce risk of cardiovascular morbidity and mortality. The patients with grade 1-2 hypertension (n=2060) and at least one additional risk factors, subclinical organ damage, established CV or renal disease, diabetes mellitus or metabolic syndrome are recruited in this...
Main Authors: | Viktoriya Borisovna Mychka, Yu V Zhernakova, Irina Evgen'evna Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2009-12-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/view/33090 |
Similar Items
-
VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL
by: Yu. N. Belenkov, et al.
Published: (2012-06-01) -
Antihypertensive effects of ACE inhibitor perindopril: ASCOT-BLPA Study lessons
by: Yu. M. Lopatin
Published: (2006-06-01) -
Perindopril arginine: a new ACE inhibitor salt increases therapeutic potential
by: Yu. A. Karpov
Published: (2008-12-01) -
Perindopril May Improve the Hippocampal Reduced Glutathione Content in Rats
by: Tahereh Mashhoody, et al.
Published: (2014-03-01) -
Final results of STRATEGYA Study (Russian Comparative Programme on a fixed,low-dose perindopril/indapamide combination efficacy in hypertensive patients with inadequateblood pressure control): use of a fixed, low- dose perindopril/indapamide combination in hypertensivepatients in real clinical practice
by: Tamila Vital'evna Martynyuk, et al.
Published: (2009-03-01)